Transplant Diagnostics Market 2018: Absolutely Paramount with Rise in Healthcare Technology Showing Huge Progress 7.2% of CAGR - Forecast Till 2023

Universal Transplant Diagnostics Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Transplant Diagnostics Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.

Global Transplant Diagnostics Market   - Overview

Transplant diagnostic are test which are performed during organ transplantation to identify the compatibility of the organ. This test is mainly performed to reduce the risk of the organ rejection. Organ transplantation is performed to treat organ failure such as lungs, liver, kidney and many more. Kidney is the most widely transplanted organ. According to National Kidney Foundation over 3,000 new patients are added to the kidney waiting list each month worldwide. Global transplant diagnostics market is driven by increasing number of people suffering from chronic diseases which frequently leading to organ failure and adoption of stem cell therapy. Beside this increasing demand for the organ transplant, increasing prevalence of diseases like diabetes, renal diseases and many more, over consumption of alcohol and unhealthy diet has also contributed into growth of the market. Whereas limited number of donor and high cost of the diagnosis methods has restrain the growth of the market. Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period 2017-2023.

Avail Sample copy of the report @ https://www.marketresearchfuture.com/sample_request/1324 .

Further Transplantation of organs, tissues and cells are now effective therapies across a wide range of both fatal and non-fatal diseases. The outstanding survival and success rates of transplantation of organs and cells, such as the kidney, liver and heart or haematopoietic stem cells in immunosuppressed patients, have led to extraordinary levels of demand globally. The rate of success for transplantation of certain cells or tissues which do not involve immunosuppression have also confirmed that such procedures are regularly the treatment of choice in the respective therapeutic areas. It is, nevertheless, clear that ethically-unacceptable practices occur in a number of countries globally. In spite of the appropriate focus on prevention of the disease, the global needs of patients for transplantation are not being met. The demand has surpassed the supply of organs, cells and tissues from both deceased donors and from the unselfish living relatives of patients in need of organs. The alternate treatments and medical support for patients with end stage organ failure, particularly renal dialysis, are expensive and narrowed down in various countries globally. There is also a lack of clinical expertise in some regions and countries and an incapability for fund transplantation to some extent in all countries around the world.

Key Players for Global Transplant Diagnostics Market:

Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US).

Segmentation:

Global Transplant Diagnostics Market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, and kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centres, research laboratories and other.

Global Transplant Diagnostics Market   - Competitive Analysis

Thermo Fisher Scientific Acquires Linkage Bio: on July 2017 Thermo Fisher Scientific confirmed the company's acquisition of Linkage Biosciences for an undisclosed amount, as a result of this acquisition Linkage Biosciences is now a part of Thermo Fisher's transplant diagnostics business. The company based in South San Francisco, California. Benefits involved from the acquisition include a broader and deeper range of products, a continued commitment to innovation, and expanded support globally.

The business is extremely complementary to the company's One Lambda tests, which regulate the compatibility of donors and recipients pre- and post-transplant. This acquisition further expands Thermo Fisher's commitment of improving transplant patients' quality of life over innovative high-quality products for the clinical and research segments of the transplant community.

Customization on this Report, Ask to Expert @ https://www.marketresearchfuture.com/enquiry/1324 .

Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US) are some of the major players in the Global Transplant Diagnostics Market.

TOC of Transplant Diagnostics Market:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS

5.1 INSTRUMENT

5.2 REAGENT

5.3 SOFTWARE AND SERVICES

6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

6.1 NON-MOLECULAR ASSAY

6.1.1 SEROLOGICAL ASSAY

6.1.2 MIXED LYMPHOCYTE CULTURE

6.2 MOLECULAR ASSAY

6.2.1 SEQUENCED BASE

6.2.2 PCR BASED

7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

TOC CONTINUED…!

Key Questions Answered In This Report:

What will the market size and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Avail Marvelous Discount @ https://www.marketresearchfuture.com/check-discount/1324 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.